Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Melanoma | 24 | 2023 | 5694 | 1.140 |
Why?
|
Skin Neoplasms | 14 | 2024 | 5809 | 0.630 |
Why?
|
Carcinoma, Merkel Cell | 3 | 2024 | 328 | 0.450 |
Why?
|
Stromal Cells | 2 | 2016 | 1329 | 0.390 |
Why?
|
Epithelial-Mesenchymal Transition | 1 | 2016 | 736 | 0.380 |
Why?
|
Antigens, Neoplasm | 3 | 2022 | 1985 | 0.300 |
Why?
|
Cancer Vaccines | 3 | 2021 | 1038 | 0.260 |
Why?
|
Killer Cells, Natural | 3 | 2020 | 2194 | 0.260 |
Why?
|
Cell Proliferation | 3 | 2020 | 10423 | 0.240 |
Why?
|
Lymphocytes, Tumor-Infiltrating | 2 | 2022 | 1089 | 0.240 |
Why?
|
Cell Movement | 1 | 2016 | 5195 | 0.230 |
Why?
|
Neoplasm Metastasis | 6 | 2019 | 4909 | 0.210 |
Why?
|
DNA Barcoding, Taxonomic | 1 | 2023 | 132 | 0.210 |
Why?
|
Histocompatibility Antigens Class I | 2 | 2020 | 1348 | 0.200 |
Why?
|
Nevus, Blue | 1 | 2022 | 43 | 0.200 |
Why?
|
Neoplasm Recurrence, Local | 6 | 2024 | 9278 | 0.200 |
Why?
|
Drug Resistance, Neoplasm | 5 | 2020 | 5301 | 0.190 |
Why?
|
Immunity, Cellular | 2 | 2020 | 1553 | 0.190 |
Why?
|
Neoplasm Invasiveness | 3 | 2018 | 3590 | 0.180 |
Why?
|
Tumor Cells, Cultured | 5 | 2022 | 6125 | 0.180 |
Why?
|
Activating Transcription Factor 3 | 1 | 2020 | 58 | 0.180 |
Why?
|
Tumor Microenvironment | 5 | 2023 | 3875 | 0.170 |
Why?
|
Uveal Neoplasms | 1 | 2022 | 341 | 0.160 |
Why?
|
RNA Stability | 1 | 2019 | 317 | 0.140 |
Why?
|
Antibodies, Blocking | 1 | 2018 | 249 | 0.140 |
Why?
|
Genomics | 3 | 2023 | 5829 | 0.140 |
Why?
|
Receptors, Antigen, T-Cell | 2 | 2023 | 2549 | 0.140 |
Why?
|
Single-Cell Analysis | 4 | 2023 | 2452 | 0.130 |
Why?
|
Epitopes | 2 | 2021 | 2504 | 0.130 |
Why?
|
Suppressor of Cytokine Signaling Proteins | 1 | 2017 | 178 | 0.130 |
Why?
|
Testicular Neoplasms | 1 | 2022 | 801 | 0.130 |
Why?
|
MutS Homolog 2 Protein | 1 | 2016 | 197 | 0.130 |
Why?
|
Cyclin-Dependent Kinase 6 | 1 | 2018 | 348 | 0.130 |
Why?
|
Tumor Escape | 1 | 2018 | 371 | 0.130 |
Why?
|
T-Lymphocytes, Cytotoxic | 2 | 2020 | 1783 | 0.120 |
Why?
|
Culture Media, Conditioned | 1 | 2016 | 522 | 0.120 |
Why?
|
Cyclin-Dependent Kinase 4 | 1 | 2018 | 559 | 0.120 |
Why?
|
Immunologic Memory | 1 | 2021 | 1361 | 0.110 |
Why?
|
Gene Expression Regulation, Neoplastic | 5 | 2020 | 8531 | 0.110 |
Why?
|
Nevus, Pigmented | 1 | 2015 | 222 | 0.110 |
Why?
|
Vacuolar Proton-Translocating ATPases | 1 | 2014 | 195 | 0.110 |
Why?
|
Proto-Oncogene Proteins B-raf | 3 | 2019 | 2054 | 0.110 |
Why?
|
Adenocarcinoma | 3 | 2016 | 6341 | 0.110 |
Why?
|
Lymph Node Excision | 1 | 2019 | 1270 | 0.110 |
Why?
|
Proto-Oncogene Proteins c-bcl-2 | 1 | 2019 | 1404 | 0.110 |
Why?
|
Conserved Sequence | 1 | 2016 | 1162 | 0.100 |
Why?
|
Coculture Techniques | 1 | 2016 | 1334 | 0.100 |
Why?
|
Neoplasm Staging | 5 | 2020 | 11119 | 0.100 |
Why?
|
CD4-Positive T-Lymphocytes | 2 | 2022 | 4373 | 0.100 |
Why?
|
Antibodies, Monoclonal | 3 | 2020 | 9187 | 0.100 |
Why?
|
Pancreatectomy | 1 | 2016 | 811 | 0.090 |
Why?
|
Cell Line, Tumor | 8 | 2020 | 16954 | 0.090 |
Why?
|
Cell Nucleus | 1 | 2020 | 2881 | 0.090 |
Why?
|
Transcriptional Activation | 1 | 2017 | 1749 | 0.090 |
Why?
|
Neoplasms, Multiple Primary | 1 | 2015 | 592 | 0.090 |
Why?
|
Early Diagnosis | 1 | 2016 | 1186 | 0.090 |
Why?
|
Mice, Nude | 3 | 2020 | 3606 | 0.080 |
Why?
|
Indoles | 1 | 2017 | 1830 | 0.080 |
Why?
|
NK Cell Lectin-Like Receptor Subfamily K | 2 | 2020 | 95 | 0.080 |
Why?
|
Interferon-gamma | 1 | 2017 | 3155 | 0.080 |
Why?
|
Mice | 12 | 2023 | 81330 | 0.080 |
Why?
|
Proto-Oncogene Proteins p21(ras) | 1 | 2016 | 1746 | 0.080 |
Why?
|
Molecular Targeted Therapy | 1 | 2019 | 2813 | 0.080 |
Why?
|
Mutation | 5 | 2022 | 30004 | 0.070 |
Why?
|
Genetic Loci | 1 | 2017 | 2623 | 0.070 |
Why?
|
ras Proteins | 2 | 2018 | 1055 | 0.070 |
Why?
|
Humans | 38 | 2024 | 761222 | 0.070 |
Why?
|
Monocytes | 1 | 2017 | 2570 | 0.070 |
Why?
|
Protein Kinase Inhibitors | 3 | 2018 | 5665 | 0.070 |
Why?
|
Lymph Nodes | 1 | 2019 | 3461 | 0.070 |
Why?
|
Sulfonamides | 1 | 2017 | 1977 | 0.070 |
Why?
|
T-Lymphocytes | 3 | 2022 | 10203 | 0.070 |
Why?
|
SOS1 Protein | 1 | 2007 | 40 | 0.070 |
Why?
|
Embryonic Stem Cells | 1 | 2014 | 1246 | 0.070 |
Why?
|
Neural Stem Cells | 1 | 2014 | 886 | 0.070 |
Why?
|
Melanoma, Experimental | 2 | 2020 | 561 | 0.070 |
Why?
|
Signal Transduction | 5 | 2019 | 23419 | 0.060 |
Why?
|
Sequence Analysis, RNA | 3 | 2020 | 2011 | 0.060 |
Why?
|
Cell Transformation, Neoplastic | 1 | 2015 | 2820 | 0.060 |
Why?
|
Antineoplastic Agents | 2 | 2018 | 13632 | 0.060 |
Why?
|
Animals | 14 | 2023 | 168089 | 0.060 |
Why?
|
Genome, Human | 1 | 2017 | 4423 | 0.060 |
Why?
|
Ligands | 2 | 2023 | 3264 | 0.060 |
Why?
|
Insurance, Health | 1 | 2016 | 2493 | 0.060 |
Why?
|
Palatine Tonsil | 1 | 2023 | 193 | 0.050 |
Why?
|
Stomach Neoplasms | 1 | 2013 | 1457 | 0.050 |
Why?
|
MAP Kinase Signaling System | 2 | 2020 | 1480 | 0.050 |
Why?
|
Response Elements | 1 | 2023 | 306 | 0.050 |
Why?
|
Base Sequence | 3 | 2019 | 12404 | 0.050 |
Why?
|
GTP-Binding Protein alpha Subunits | 1 | 2022 | 102 | 0.050 |
Why?
|
Oncogene Protein v-akt | 1 | 2020 | 129 | 0.050 |
Why?
|
RNA | 2 | 2023 | 2709 | 0.040 |
Why?
|
Chemokines, C | 1 | 2019 | 10 | 0.040 |
Why?
|
Tristetraprolin | 1 | 2019 | 38 | 0.040 |
Why?
|
Apoptosis | 3 | 2020 | 9478 | 0.040 |
Why?
|
Mitogen-Activated Protein Kinases | 2 | 2019 | 1240 | 0.040 |
Why?
|
Cross-Priming | 1 | 2019 | 76 | 0.040 |
Why?
|
Algorithms | 1 | 2020 | 14025 | 0.040 |
Why?
|
Freezing | 1 | 2020 | 311 | 0.040 |
Why?
|
SEER Program | 2 | 2015 | 1453 | 0.040 |
Why?
|
Organ Specificity | 1 | 2023 | 1963 | 0.040 |
Why?
|
Calcium-Binding Proteins | 1 | 2023 | 1067 | 0.040 |
Why?
|
RNA, Double-Stranded | 1 | 2020 | 290 | 0.040 |
Why?
|
Antigen-Presenting Cells | 1 | 2022 | 965 | 0.040 |
Why?
|
Male | 14 | 2024 | 360703 | 0.040 |
Why?
|
Cell Culture Techniques | 2 | 2017 | 1662 | 0.040 |
Why?
|
Pancreatic Neoplasms | 1 | 2016 | 5366 | 0.040 |
Why?
|
Survival Rate | 3 | 2019 | 12728 | 0.040 |
Why?
|
Immunocompetence | 1 | 2018 | 138 | 0.040 |
Why?
|
Phosphatidylinositol 3-Kinases | 2 | 2018 | 2864 | 0.040 |
Why?
|
Female | 14 | 2024 | 392552 | 0.040 |
Why?
|
Caenorhabditis elegans | 1 | 2007 | 1453 | 0.040 |
Why?
|
Retrospective Studies | 6 | 2024 | 80675 | 0.040 |
Why?
|
Adaptive Immunity | 1 | 2022 | 724 | 0.040 |
Why?
|
Endothelial Cells | 2 | 2023 | 3552 | 0.040 |
Why?
|
Cell Adhesion Molecules | 1 | 2023 | 1603 | 0.040 |
Why?
|
Aged | 9 | 2024 | 169292 | 0.030 |
Why?
|
Transcription Initiation Site | 1 | 2017 | 187 | 0.030 |
Why?
|
Aged, 80 and over | 5 | 2024 | 58952 | 0.030 |
Why?
|
Membrane Proteins | 1 | 2014 | 7851 | 0.030 |
Why?
|
Mutagenesis, Site-Directed | 1 | 2020 | 1681 | 0.030 |
Why?
|
Remission, Spontaneous | 1 | 2017 | 384 | 0.030 |
Why?
|
Transcription Factor Brn-3A | 1 | 2016 | 13 | 0.030 |
Why?
|
Time-Lapse Imaging | 1 | 2017 | 194 | 0.030 |
Why?
|
Kaplan-Meier Estimate | 2 | 2020 | 6486 | 0.030 |
Why?
|
HLA Antigens | 1 | 2022 | 1331 | 0.030 |
Why?
|
Axilla | 1 | 2019 | 624 | 0.030 |
Why?
|
Cell Differentiation | 3 | 2022 | 11512 | 0.030 |
Why?
|
Mice, Inbred C57BL | 3 | 2020 | 22128 | 0.030 |
Why?
|
CD8-Positive T-Lymphocytes | 2 | 2022 | 4574 | 0.030 |
Why?
|
Gene Expression Profiling | 2 | 2023 | 9417 | 0.030 |
Why?
|
Spheroids, Cellular | 1 | 2017 | 329 | 0.030 |
Why?
|
Transforming Growth Factor beta | 1 | 2023 | 1963 | 0.030 |
Why?
|
Clinical Trials, Phase III as Topic | 1 | 2019 | 858 | 0.030 |
Why?
|
Mice, Inbred NOD | 1 | 2020 | 1822 | 0.030 |
Why?
|
Chemokines | 1 | 2019 | 956 | 0.030 |
Why?
|
Lung Neoplasms | 1 | 2020 | 13386 | 0.030 |
Why?
|
Promoter Regions, Genetic | 2 | 2017 | 5773 | 0.030 |
Why?
|
Placebos | 1 | 2019 | 1666 | 0.030 |
Why?
|
Colorectal Neoplasms | 1 | 2015 | 6919 | 0.030 |
Why?
|
Radiotherapy, Adjuvant | 1 | 2020 | 1784 | 0.030 |
Why?
|
Middle Aged | 9 | 2024 | 220858 | 0.030 |
Why?
|
Brain Neoplasms | 1 | 2016 | 9025 | 0.030 |
Why?
|
Neurofibromin 1 | 1 | 2016 | 190 | 0.030 |
Why?
|
Mice, SCID | 1 | 2020 | 2621 | 0.030 |
Why?
|
Receptors, IgG | 1 | 2018 | 558 | 0.030 |
Why?
|
Mice, Knockout | 2 | 2020 | 14392 | 0.030 |
Why?
|
Phenotype | 3 | 2022 | 16575 | 0.030 |
Why?
|
Multicenter Studies as Topic | 1 | 2019 | 1702 | 0.030 |
Why?
|
GTP-Binding Protein alpha Subunits, Gq-G11 | 1 | 2015 | 147 | 0.030 |
Why?
|
Microphthalmia-Associated Transcription Factor | 1 | 2016 | 258 | 0.030 |
Why?
|
High-Throughput Nucleotide Sequencing | 2 | 2017 | 3634 | 0.030 |
Why?
|
HeLa Cells | 1 | 2020 | 3073 | 0.030 |
Why?
|
Receptors, Immunologic | 1 | 2020 | 1408 | 0.030 |
Why?
|
Postoperative Complications | 1 | 2016 | 15637 | 0.030 |
Why?
|
Cross-Over Studies | 1 | 2019 | 2082 | 0.030 |
Why?
|
Histocompatibility Antigens Class II | 1 | 2017 | 1435 | 0.030 |
Why?
|
Matrix Metalloproteinase 9 | 1 | 2016 | 631 | 0.030 |
Why?
|
Immunophenotyping | 1 | 2017 | 1867 | 0.030 |
Why?
|
Vascular Endothelial Growth Factor A | 1 | 2023 | 3493 | 0.030 |
Why?
|
Ubiquitin Thiolesterase | 1 | 2015 | 455 | 0.030 |
Why?
|
Leg | 1 | 2017 | 1087 | 0.030 |
Why?
|
Microtubule-Associated Proteins | 1 | 2017 | 1075 | 0.020 |
Why?
|
Melanocytes | 1 | 2015 | 509 | 0.020 |
Why?
|
Chromatin | 1 | 2023 | 2946 | 0.020 |
Why?
|
Class I Phosphatidylinositol 3-Kinases | 1 | 2016 | 899 | 0.020 |
Why?
|
Xenograft Model Antitumor Assays | 1 | 2020 | 3593 | 0.020 |
Why?
|
Immunotherapy | 2 | 2018 | 4642 | 0.020 |
Why?
|
Lymphatic Metastasis | 1 | 2019 | 2913 | 0.020 |
Why?
|
Amino Acid Sequence | 2 | 2017 | 13402 | 0.020 |
Why?
|
Chemotherapy, Adjuvant | 1 | 2019 | 3512 | 0.020 |
Why?
|
Follow-Up Studies | 3 | 2019 | 39127 | 0.020 |
Why?
|
Microfluidic Analytical Techniques | 1 | 2017 | 799 | 0.020 |
Why?
|
Neoplasms | 1 | 2020 | 22142 | 0.020 |
Why?
|
Hippocampus | 1 | 2023 | 3754 | 0.020 |
Why?
|
Immunity, Humoral | 1 | 2014 | 598 | 0.020 |
Why?
|
Epigenesis, Genetic | 1 | 2023 | 3788 | 0.020 |
Why?
|
Receptors, Androgen | 1 | 2016 | 1077 | 0.020 |
Why?
|
Phosphorylation | 1 | 2020 | 8300 | 0.020 |
Why?
|
Proto-Oncogene Proteins c-akt | 1 | 2018 | 2455 | 0.020 |
Why?
|
Disease-Free Survival | 1 | 2019 | 6819 | 0.020 |
Why?
|
Adult | 6 | 2020 | 221120 | 0.020 |
Why?
|
TOR Serine-Threonine Kinases | 1 | 2018 | 2058 | 0.020 |
Why?
|
Cell Communication | 1 | 2016 | 1651 | 0.020 |
Why?
|
Child | 3 | 2022 | 80154 | 0.020 |
Why?
|
Double-Blind Method | 1 | 2022 | 12341 | 0.020 |
Why?
|
Computational Biology | 1 | 2020 | 3499 | 0.020 |
Why?
|
Gastrectomy | 1 | 2013 | 672 | 0.020 |
Why?
|
Cell Cycle | 1 | 2016 | 2926 | 0.020 |
Why?
|
Microscopy, Confocal | 1 | 2014 | 1967 | 0.020 |
Why?
|
Immunity, Innate | 1 | 2019 | 3044 | 0.020 |
Why?
|
Flow Cytometry | 1 | 2017 | 5871 | 0.020 |
Why?
|
Up-Regulation | 1 | 2016 | 4111 | 0.020 |
Why?
|
HEK293 Cells | 1 | 2016 | 4243 | 0.020 |
Why?
|
Tumor Burden | 1 | 2013 | 1892 | 0.020 |
Why?
|
raf Kinases | 1 | 2007 | 118 | 0.020 |
Why?
|
Homeostasis | 1 | 2017 | 3322 | 0.020 |
Why?
|
Dendritic Cells | 1 | 2017 | 2726 | 0.020 |
Why?
|
Young Adult | 3 | 2019 | 59222 | 0.020 |
Why?
|
Tumor Suppressor Proteins | 1 | 2015 | 2803 | 0.020 |
Why?
|
Lymphocyte Activation | 1 | 2016 | 5478 | 0.020 |
Why?
|
Prognosis | 2 | 2016 | 29688 | 0.010 |
Why?
|
RNA, Messenger | 1 | 2019 | 12747 | 0.010 |
Why?
|
RNA, Small Interfering | 1 | 2014 | 3412 | 0.010 |
Why?
|
Biopsy | 1 | 2016 | 6781 | 0.010 |
Why?
|
Epidermal Growth Factor | 1 | 2007 | 699 | 0.010 |
Why?
|
Transcription Factors | 1 | 2023 | 12101 | 0.010 |
Why?
|
Immunohistochemistry | 1 | 2017 | 11067 | 0.010 |
Why?
|
Protein Binding | 1 | 2016 | 9297 | 0.010 |
Why?
|
Adolescent | 3 | 2019 | 88300 | 0.010 |
Why?
|
Survival Analysis | 1 | 2016 | 10088 | 0.010 |
Why?
|
Massachusetts | 1 | 2016 | 8837 | 0.010 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2019 | 10218 | 0.010 |
Why?
|
Sequence Alignment | 1 | 2007 | 2175 | 0.010 |
Why?
|
Cytokines | 1 | 2017 | 7386 | 0.010 |
Why?
|
Transcription, Genetic | 1 | 2016 | 7571 | 0.010 |
Why?
|
Socioeconomic Factors | 1 | 2016 | 7804 | 0.010 |
Why?
|
Palliative Care | 1 | 2017 | 3599 | 0.010 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 1 | 2022 | 11733 | 0.010 |
Why?
|
Enzyme Activation | 1 | 2007 | 3577 | 0.010 |
Why?
|
Combined Modality Therapy | 1 | 2013 | 8519 | 0.010 |
Why?
|
Disease Models, Animal | 1 | 2020 | 18222 | 0.010 |
Why?
|
Protein Structure, Tertiary | 1 | 2007 | 3778 | 0.010 |
Why?
|
Models, Biological | 1 | 2016 | 9458 | 0.010 |
Why?
|
RNA Interference | 1 | 2007 | 2816 | 0.010 |
Why?
|
Proportional Hazards Models | 1 | 2013 | 12474 | 0.010 |
Why?
|
Incidence | 1 | 2016 | 21366 | 0.010 |
Why?
|
Models, Molecular | 1 | 2007 | 5406 | 0.010 |
Why?
|
Brain | 1 | 2023 | 27094 | 0.010 |
Why?
|
Age Factors | 1 | 2013 | 18384 | 0.010 |
Why?
|
Time Factors | 1 | 2016 | 39957 | 0.010 |
Why?
|
Molecular Sequence Data | 1 | 2007 | 17598 | 0.010 |
Why?
|
Treatment Outcome | 1 | 2020 | 64681 | 0.010 |
Why?
|
Genetic Predisposition to Disease | 1 | 2015 | 17897 | 0.010 |
Why?
|
Risk Assessment | 1 | 2013 | 24022 | 0.010 |
Why?
|